Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JH

James A. Hoffmann — 39 Patents

Eli Lilly: 34 patents #40 of 2,858Top 2%
AAAbb Flexible Automation: 2 patents #7 of 41Top 20%
ASAres Trading S.A.: 2 patents #48 of 249Top 20%
FIFournitures Hospitalieres Industrie: 1 patents #5 of 20Top 25%
UNUnknown: 1 patents #29,356 of 83,584Top 40%
Durham, PA: #1 of 6 inventorsTop 20%
Pennsylvania: #1,169 of 74,527 inventorsTop 2%
Overall (All Time): #81,245 of 4,157,543Top 2%
39 Patents All Time
James A. Hoffmann has been granted 39 US patents while listed as an inventor at Eli Lilly. The first was granted in 1983 and the most recent in January 2019. James A. Hoffmann ranks #81,245 of 4,157,543 US inventors in our database (top 2.0%). Patent records list James A. Hoffmann in Durham, PA, US.

Issued Patents All Time

Showing 1–25 of 39 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10188408 Glenoid cavity bone preparation set for setting a shoulder prosthesis, and method for implanting a shoulder prosthesis Guillaume Francois Antoine Rouyer, Bruce Wayne Miller 2019-01-29
RE41133 Glucagon-like peptide-1 crystals Ronald Norbert Hermeling, Chakravarthy Nachu Narasimhan 2010-02-16
7563763 FSH and FSH variant formulations, products and methods Jirong Lu 2009-07-21
7446090 FSH formulation Jirong Lu 2008-11-04
7232879 Glucagon-like insulinotropic peptides, compositions and methods John A. Galloway 2007-06-19 $167,908,000
6703365 Glucagon-like insulinotropic peptides, compositions and methods John A. Galloway 2004-03-09 $149,189,000
6555521 Glucagon-like peptide-1 crystals Ronald Norbert Hermeling, Chakravarthy Nachu Narasimhan 2003-04-29 $249,179,000
6388053 Glucagon-like insulinotropic peptides, compositions and methods John A. Galloway 2002-05-14 $122,149,000
6380357 Glucagon-like peptide-1 crystals Ronald Norbert Hermeling, Chakravarthy Nachu Narasimhan 2002-04-30 $98,315,000
6358924 GLP-1 formulations 2002-03-19 $63,225,000
6133235 Glucagon-like insulinotropic peptides compositions and methods John A. Galloway 2000-10-17 $162,752,000
6024349 Compliant end effector for an industrial robot Douglas L. St. Onge 2000-02-15
5981488 Glucagon-like peptide-1 analogs 1999-11-09 $103,079,000
5977071 Glucagon-like insulinotropic peptides, compositions and methods John A. Galloway 1999-11-02 $60,888,000
5851995 Anti-obesity proteins Margret B. Basinski, Richard D. DiMarchi, David B. Flora, William F. Heath, Jr., Brigitte E. Schoner +2 more 1998-12-22 $170,171,000
5831017 Obesity protein analog compounds and formulations thereof 1998-11-03 $677,177,000
5765975 Compliant end effector for an industrial robot Douglas L. St. Onge 1998-06-16 $264,000
5719266 Anti-obesity proteins Richard D. DiMarchi, Ronald Norbert Hermeling 1998-02-17 $104,522,000
5705483 Glucagon-like insulinotropic peptides, compositions and methods John A. Galloway 1998-01-06 $98,435,000
5698669 Tri-arginine insulins Peter K. Lambooy 1997-12-16 $101,032,000
5691309 Anti-obesity proteins Margret B. Basinski, Richard D. DiMarchi, David B. Flora, William F. Heath, Jr., Brigitte E. Schoner +2 more 1997-11-25 $74,311,000
5605886 Anti-obesity proteins Margret B. Basinski, Richard D. DiMarchi, David B. Flora, William F. Heath, Jr., Brigitte E. Schoner +2 more 1997-02-25 $34,301,000
5594104 Anti-obesity proteins Margret B. Basinski, Richard D. DiMarchi, David B. Flora, William F. Heath, Jr., Brigitte E. Schoner +2 more 1997-01-14 $29,464,000
5580954 Anti-obesity proteins Richard D. DiMarchi, David B. Flora, William F. Heath, Jr., James E. Shields, David L. Smiley 1996-12-03 $91,978,000
5574133 Anti-obesity proteins Richard D. DiMarchi, David B. Flora, William F. Heath, Jr., James E. Shields, David L. Smiley 1996-11-12 $16,097,000